Want to see ALDX full AI Analyst Report?
Aldeyra Therapeutics (ALDX) Income Statement
Aldeyra Therapeutics Income Statement
Last quarter (Q2 2026), Aldeyra Therapeutics's total revenue was $0.00. In Q2, Aldeyra Therapeutics's net income was $-5.45M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 35.27M | $ 60.12M | $ 42.79M | $ 62.68M | $ 56.22M | |
| Depreciation and Amortization | $ 251.99K | $ 249.62K | $ 262.78K | $ 258.71K | $ 264.18K |
| $ -31.69M | $ -53.68M | $ -35.21M | $ -60.07M | $ -55.77M | |
| $ -35.27M | $ -60.12M | $ -42.79M | $ -62.68M | $ -56.22M | |
| $ 1.42M | $ 4.27M | $ 5.25M | $ 655.35K | $ -1.56M | |
| $ -33.85M | $ -55.85M | $ -37.54M | $ -62.02M | $ -57.78M | |
| $ -33.85M | $ -55.85M | $ -37.54M | $ -62.02M | $ -57.78M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.56 | $ -0.94 | $ -0.64 | $ -1.06 | $ -1.07 |
| Diluted EPS | $ -0.56 | $ -0.94 | $ -0.64 | $ -1.06 | $ -1.07 |
| Weighted Average Shares Outstanding | 60.06M | 59.48M | 58.94M | 58.41M | 54.04M |
| Weighted Average Shares Outstanding (Diluted) | 60.06M | 59.48M | 58.94M | 58.41M | 54.04M |
Currency in USD